Mental Health Clinics in Romney, WV Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Eastern Psychological Services, Inc. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 278 N High St, Suite 1, Romney, WV 26757 Phone: 304-822-3429 Fax: 304-822-7225 |
Family Preservation Services Of West Virginia, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 285 W Birch Ln, Romney, WV 26757 Phone: 304-822-2670 |
South Branch Valley Day Report Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 25 S Grafton St, Romney, WV 26757 Phone: 304-822-3009 Fax: 304-822-2662 |
Telamon Corporation Counselor Medicare: Not Enrolled in Medicare Practice Location: 60 W Sioux Ln, Romney, WV 26757 Phone: 304-822-4514 Fax: 304-822-4515 |
Mountaineer Mental Health, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 285 W Birch Ln, Romney, WV 26757 Phone: 304-359-2380 |
Wvcorr Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 134 W Sioux Ln, Romney, WV 26757 Phone: 304-359-2185 |
News Archive
Guidance for evaluating menopause-like condition in girls and young women
A comprehensive plan to help health care professionals diagnose and treat primary ovarian insufficiency-a menopause-like condition affecting girls and young women that may occur years before normal menopause is expected-has been developed by a scientist at the National Institutes of Health.
Oncobiologics signs two major pharmaceutical agreements
Oncobiologics announced today that it has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based large pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies.
IDEAL LM study: Biodegradable polymer everolimus-eluting stent safe and effective for patients undergoing PCI
New data from the IDEAL-LM trial found that a biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) was safe and effective compared to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT in patients undergoing PCI for unprotected left main coronary artery (uLMCA) disease.
Survey: Half of all American workplaces offer health and wellness programs
Workplace health promotion programs are increasing in the U.S., according to researchers at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health, the Centers for Disease Control and Prevention, and RTI International.
› Verified 7 days ago